XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flow from operating activities:    
Net loss $ (17,821,524) $ (11,900,662)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 980,381 970,488
Vesting expense 102,894 627,329
Amortization of debt discount 0 244,830
Gain on valuation of equity-linked instruments and derivative liability (107,381) (68,884)
Equity instruments issued consultant, and other 306,792 143,523
Loss on fixed asset disposal 1,700 5,858
Loss on goodwill impairment 7,231,093 2,813,792
Changes in assets and liabilities:    
Accounts receivable 29,488 (18,315)
Inventories (106,038) (108,441)
Prepaid expense and other assets (39,928) (313,573)
Accounts payable (104,503) (342,525)
Accrued expenses and other liabilities 476,035 (412,952)
Contract liabilities (64,889) 99,518
Other long-term liabilities (19,932) (204,807)
Net cash used in operating activities: (9,135,812) (8,464,821)
Cash flow from investing activities:    
Purchase of fixed assets (361,916) (714,534)
Loan activities (55,000)
Acquisition of intangibles (50,180) (50,699)
Net cash used in investing activities (412,096) (820,233)
Cash flow from financing activities:    
Proceeds from issuance of common stock and warrants, net 6,507,050 50,523,527
Proceeds from exercise of warrants into common stock 0 4,513,860
Repayment of debt 0 (4,162,744)
Payment penalties 0 (1,073,470)
Proceeds from issuance of common stock pursuant to equity line 236,009 588,590
Repurchase of common stock upon vesting of restricted stock units (4,028) (11,526)
Net cash provided by financing activities 6,739,031 50,378,237
Net increase (decrease) in cash and cash equivalents (2,808,877) 41,093,183
Cash and cash equivalents at beginning of period 28,202,615 678,332
Cash and cash equivalents at end of period 25,393,738 41,771,515
Non-cash transactions:    
Shares issued to CEO per agreement related to accrued interest 0 143,573
Shares issued pursuant to convertible debt 0 514,011
Cash paid during period for:    
Interest paid on debt $ 3,754 $ 695,989